Literature DB >> 15037224

Cyclosporine reduces hepatic antioxidant capacity: protective roles of antioxidants.

Ilker Durak1, Hanefi Ozbek, Serenay Elgün.   

Abstract

The immunosuppressive agent cyclosporine A (CsA) has been reported to exert measurable hepatotoxic effects. One of the causes leading to hepatotoxicity is thought to be reactive oxygen radical formation. Therefore, this study was designed to elucidate possible relation between cyclosporine A treatment and antioxidant capacity (AOC) of hepatic tissue and, to determine if antioxidant supplementation is beneficial. Cyclosporine A was given to 20 rabbits orally for 10 days. Vitamins E and C combination were given intramuscularly. Vitamin therapy was started 3 days before cyclosporine A treatment and continued for 10 days. In each group (control, cyclosporine A, cyclosporine A+vitamin, and vitamin only) there were five animals. After the animals were sacrificed, their livers were removed to be used in the AOC measurement. AOC was found to be lower in cyclosporine A group compared to control and vitamin groups. Results suggest that reduced antioxidant capacity may play part in the cyclosporine A-induced hepatotoxicity and use of some antioxidants may give beneficial results.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037224     DOI: 10.1016/j.intimp.2004.01.018

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

1.  Provinol prevents CsA-induced nephrotoxicity by reducing reactive oxygen species, iNOS, and NF-kB expression.

Authors:  Barbara Buffoli; Olga Pechánová; Stanislava Kojsová; Ramaroson Andriantsitohaina; Lorena Giugno; Rossella Bianchi; Rita Rezzani
Journal:  J Histochem Cytochem       Date:  2005-06-13       Impact factor: 2.479

2.  The ameliorative impacts of wheat germ oil against ethanol-induced gastric ulcers: involvement of anti-inflammatory, antiapoptotic, and antioxidant activities.

Authors:  Rabab Shaban El-Shafey; Samar H Baloza; Lina Abdelhady Mohammed; Hend Elsayed Nasr; Mohamed Mohamed Soliman; Heba I Ghamry; Salwa A Elgendy
Journal:  Toxicol Res (Camb)       Date:  2022-03-31       Impact factor: 2.680

3.  Cyclosporin A activates human hepatocellular carcinoma (HepG2 cells) proliferation: implication of EGFR-mediated ERK1/2 signaling pathway.

Authors:  Mohammed E Abo-El Fetoh; Gouda K Helal; I G Saleh; M Ewees; Mohamed ElShafey; Mohamed R Elnagar; El-Sayed Akool
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-01-06       Impact factor: 3.000

4.  Role of sulphated polysaccharides from Sargassum Wightii in Cyclosporine A-induced oxidative liver injury in rats.

Authors:  Anthony Josephine; Kalaiselvam Nithya; Ganapathy Amudha; Coothan Kandaswamy Veena; Sreenivasan P Preetha; Palaninathan Varalakshmi
Journal:  BMC Pharmacol       Date:  2008-02-20

5.  Effect of cyclosporine-a on paraoxonase activity in wistar rats.

Authors:  H Argani; A Ghorbanihaghjo; N Rashtchizadeh; S Seifirad; Y Rahbarfar
Journal:  Int J Organ Transplant Med       Date:  2011

6.  Oxidative Stress and Liver Morphology in Experimental Cyclosporine A-Induced Hepatotoxicity.

Authors:  Agnieszka Korolczuk; Kinga Caban; Magdalena Amarowicz; Grażyna Czechowska; Joanna Irla-Miduch
Journal:  Biomed Res Int       Date:  2016-05-19       Impact factor: 3.411

7.  The Comparison of Parameters of Oxidative Stress in Native Rat Livers Between Different Immunosuppressive Regimens.

Authors:  Aleksandra Wilk; Dagmara Szypulska-Koziarska; Karolina Kędzierska-Kapuza; Jerzy Sieńko; Agnieszka Kolasa-Wołosiuk; Kazimierz Ciechanowski; Barbara Wiszniewska
Journal:  Med Sci Monit       Date:  2019-11-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.